Hepatotoxicity and Drug-Induced Liver Injury

Hepatotoxicity occurs when toxins or drugs cause liver damage, which can lead to liver failure or chronic liver disease. Drug-induced liver injury (DILI) is a leading cause of liver transplantation. Research focuses on identifying early biomarkers, understanding metabolic pathways that contribute to toxicity, and developing safer pharmaceuticals. Improved preclinical screening and personalized medicine approaches help predict which patients are at higher risk for DILI, improving the safety of new drugs and treatments.

    Related Conference of Hepatotoxicity and Drug-Induced Liver Injury

    November 28-29, 2024

    19th World Convention on Waste Recycling and Reuse

    Paris, France
    February 13-14, 2025

    4th World Congress on Endocrinology & Diabetes

    Rome, Italy
    February 24-25, 2025

    4th World Congress on Sustainable Waste Management

    Madrid, Spain
    April 14-15, 2025

    13th World Conference on Climate Change

    Aix-en-Provence, France
    April 14-15, 2025

    6th Global Summit on Environmental Health

    Amsterdam, Netherlands
    June 16-17, 2025

    20th World Bioenergy Congress and Expo

    Frankfurt, Germany
    August 26-27, 2025

    13th International Conference on Green Energy

    Paris, France

    Hepatotoxicity and Drug-Induced Liver Injury Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in